bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.10.26.564126

Rhodococcus equi Escapes Macrophage Autophagy: VapA Inhibits ATP6V0d1-Mediated Lysosomal Degradation

Abstract

Rhodococcus equi is a gram-positive actinomycetales bacterial, which cause a pneumonia in foals and in immunocompromised humans. Virulence associated protein A (VapA) encoded from virulence plasmid is essential for intracellular proliferation in macrophage. It has reported that VapA participates in exclusion of proton-pumping vacuolar-ATPase complex from phagosome and causes membrane permeabilization, thus contributing to a pH-neutral phagosome lumen. However, there have been no reports about VapA-induced autophagy or its mechanism. In this study, we sought to determine the role of VapA in macrophage autophagy using western blotting, immunofluorescence, pull-down, Co-IP, LS/MS, pH detection LysoTracker and CFU analysis. We show that VapA inhibiting the macrophage autophagy by detecting the expression of autophagy related protein LC3II and P62 and autophagy flux in VapA treated macrophage. Furthermore, we using pull-down and MS analysis to selected ATP6V0D1 could interact with VapA, Co-IP was used to confirm its interaction. Furthermore, VapA treatment in ATP6V0D1 overexpressed cells weaken the lyso Tracker red stain comparing with ATP6V0D1 overexpressed J774A.1 cells. In addition, the expression of ATP6V0D1 significantly increased in J774A.1 post infected with vapA deletion strain, R. equi 103+/{Delta}VapA by comparing with wild type R. equi 103+ post-infection. And raise of raise of ATP6V0D1 actually reduce R. equi 103+ intracellular multiplication. These results further suggesting a decrease of ATP6V0D1 were caused the exit of VapA in R. equi. Taken those date together, we reported that VapA mediated lysosome acidification by inhibiting the expression of ATP6V0D1, which contributing the R. equi escape macrophage autophagy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Luo, H., Feng, T., Xu, Z.. 2023-10-30. Rhodococcus equi Escapes Macrophage Autophagy: VapA Inhibits ATP6V0d1-Mediated Lysosomal Degradation. https://doi.org/10.1101/2023.10.26.564126

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗